Advertisement Search POZ Search 83 results found Advanced Search ViiV Applies for FDA and European Approval of First Two-Drug HIV Regimen Jun 1, 2017: The combo of Tivicay (dolutegravir) and Edurant (rilpivirine) showed comparable efficacy to three- and four-drug regimens in major trials. Long-Acting Antibody Treatment for Resistant HIV Continues to Show Promise Oct 5, 2017: With an FDA decision for ibalizumab pending, data about a group with multidrug resistance show that the antibody is effective. Hep C Treatment Telaprevir Gets Fast-Tracked FDA Review Jan 21, 2011: Vertex Pharmaceuticals announced on January 20 that the U.S. Food and Drug Administration (FDA) has agreed to expedite its approval review of... Gilead Seeks FDA OK for 3rd Combo Pill With New Tenofovir Jul 2, 2015: Gilead Sciences has applied to the FDA for approval of yet another combination HIV tablet including an updated version of tenofovir. Approval of Gilead and Tibotec’s New Combo HIV Pill Hits Snag Jan 26, 2011: Gilead Sciences announced January 25 that the U.S. Food and Drug Administration has refused to accept the company’s New Drug Application... Overcoming the Persistence of Stigma Mar 30, 2020: Youth activists living with HIV are speaking truth to power. PDUFA: Funny Name; Vital Program Oct 25, 2011: The vice president of Policy and Advocacy at AIDS United breaks down the FDA’s new Prescription Drug User Fee Act and how it helps speed... Gilead and Tibotec’s Combo HIV Drug Is Back on Track Feb 11, 2011: Gilead announced that it is back on track with the approval process for the combination ARV pill it is developing in partnership with... The 2017 Hepatitis C Treatment Pipeline Mar 15, 2017: The major players in the hep C pharmaceutical market are still reaching for improved treatments, with two key approvals expected this year. HIV/AIDS Funding: Data is the Key Apr 24, 2018: Funders Concerned About AIDS (FCAA) issues a call for data. HIV Spikes Among Drug Users in Middle East, North Africa Jun 23, 2014: There is a burgeoning epidemic of HIV among injection drug users in various countries in the Middle East and North Africa. Hep C Protease Inhibitor Telaprevir Now Under Review for FDA Approval Dec 2, 2010: Vertex Pharmaceuticals announced on November 23 that it has completed the submission of a New Drug Application (NDA) to the U.S. Food and... The Summit to END AIDS in America Aug 2, 2012: The take home message from the International AIDS Conference was clear: We Can End The AIDS Epidemic. Now it’s up to us to take that rhetoric... NY Senate Passes Three Measures to Benefit HIV-Positive People Jul 21, 2009: Following an impassioned speech by openly gay and HIV-positive Senator Tom Duane (D-Manhattan), the New York State Senate passed three bills l... How to Be Proactive in Challenging Times May 27, 2017: HIV and health care advocates are definitely on the defensive, but the game is far from over. [Bonus: VIDEO] Women on Top May 1, 2006: An HIV gel slides toward FDA approval How LGBT History Can Inspire Hope, Support Health, and Even Prevent HIV Oct 5, 2015: An AIDS journalist argues for strengthening LGBT confidence, pride and resilience. Time For An E-Full May 1, 2000: A HIVer’s guide to finding the most consumer-friendly online pharmacy for filling your prescriptions. FDA Lacks Authority to Prevent Rising Number of Drug Shortages, Report Says Dec 21, 2011: Pharmaceutical companies should be required to notify the U.S. Food and Drug Administration of situations that may lead to drug shortages... PrEP Reduces HIV Risk in Two Major Studies Jul 13, 2011: Two major studies provide additional evidence. PREVIOUS 1 2 3 4 5 Next Advertisement Hot topics Forums: Support and discussion Blogs: The community speaks POZ Stories: Get inspired Magazine: Search the archives HIV: The Basics Recursos de VIH/SIDA en Español AIDS Is Everyday Ask POZ